兩連板的創新醫療(002173.SZ):日前披露業績預吿及回購部分股份方案
格隆匯 1 月 21日丨連續2個漲停的創新醫療(002173.SZ)發佈股票交易異常波動公吿,公司、控股股東及實際控制人不存在應披露而未披露的重大事項,也不存在未披露的處於籌劃階段的重大事項。
公司已於2021年1月20日披露了《2020年度業績預吿》。公司預計2020年1月1日至2020年12月31日歸屬於上市公司股東的淨利潤為-3.8億元至-2.8億元,扣除非經常性損益後的淨利潤為-3.5億元至-2.5億元,營業收入為6.75億元至7.25億元,扣除後營業收入為6.72億元至7.22億元,基本每股收益為-0.84元/股至-0.62元/股。本次業績預吿是公司財務部門初步測算的結果,具體財務數據以公司經會計師事務所審計的《2020年年度報吿》為準。敬請廣大投資者謹慎決策,注意投資風險。
公司於2021年1月19日召開了第六屆董事會第三次會議,審議通過了《關於回購部分社會公眾股份的議案》,並於2021年1月20日上披露了《關於回購部分社會公眾股份方案的公吿》。截至目前,公司回購股份事項尚未開始。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.